We are a science led probiotic company and we develop best in class, clinically supported healthcare and nutritional products for consumers and partners worldwide.

Shandon_bells_cork-halftone.jpg

Headquaters:

Cork,


Ireland

Brian-Halftone.jpg

PAtents: 250 +

AH Team.jpg

EmpLoYees:

25

Bacteria_Blue_White_L_iStock-177518323-AH Home.png

Market Leading ProbIotic Cultures

Alflorex_Caps_30_UKen_750px_72dpi_15_032018.jpg

35624® Culture

35624® for management of symptoms including bloating & gas, abdominal pain, unpredictable diarrohea and constipation. Now the No 1 recommended probiotic by US Gastroenterologists and Doctors*. Manages all cardinal symptoms of IBS. Currently commercialised as a food supplement - Alflorex® (in Europe and Latin America), Align® - by our partner P&G in North America and Australia.

Zenflore_Caps_30_UKen_1500px_72dpi_110_032018.jpg

1714-Serenitas®

One of the first probiotics clinically proven to reduce levels of the stress hormone, cortisol.***. With growing interest in the potential of the gut-brain axis and 'psychobiotics', the 1714 culture has demonstrated ground breaking clinical activity (ENCK?) and safety. It is currently commercialised as a food supplement in Europe, Zenflore®.

Terrestrial_globe.svg.jpg

Key Markets:


EUrope
North America


Latin America

Sign Post-halftone-ex long.jpg

Key Dates

1999: Founded as an R&D company

2009: P&G launch Align containing our bifidobacterium longum 35624 culture

2014 - current: Launch of 35624 in Ireland and subsequently in EU and Latin America

2018: Launch of Zenflore in Europe containing our 1714-Serenitas culture


Enter References